The Medical Devices sector report, “Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Artificial Pancreas pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Artificial Pancreas helps people with diabetes, primarily type 1, automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Artificial Pancreas helps people with diabetes, primarily type 1, automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Artificial Pancreas under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Artificial Pancreas under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Artificial Pancreas - Pipeline Products under Development by Companies
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Admetsys Corp
- Advanced Biosensors-Ohio LLC
- AiTA Bio Inc
- Beta Bionics Inc
- Beta-O2 Technologies Ltd
- Bigfoot Biomedical Inc
- BioTex Inc
- Captix Biomedical Pty Ltd
- Cerco Medical LLC
- Children's Hospital of Philadelphia
- Converge Biotech, Inc.
- Covalor Medical, LLC
- De Montfort University
- Debiotech SA
- Defymed SAS
- Diabeloop SA
- EOFlow Co Ltd
- Giner Inc
- Haimai Medical Technology Co Ltd
- Harvard John A Paulson School of Engineering and Applied Sciences
- Healios Inc
- Humacyte Inc
- Ideal Medical Technologies Inc
- Imperial College London
- Indian Institute of Science
- Joslin Diabetes Center
- Kailian Medical Technology Co Ltd
- Kencak LLC
- Massachusetts Institute of Technology
- McGill University
- Medtronic Inc
- Medtronic MiniMed Inc
- MicroTech Medical Inc
- Miromatrix Medical Inc
- Modular Medical Inc
- Novoculi
- Pacific Diabetes Technologies Inc
- Pancreum, LLC
- PharmaCyte Biotech Inc
- Polytechnic University of Valencia
- Rensselaer Polytechnic Institute
- Senseonics Holdings Inc
- SFC Fluidics LLC
- Shenzhen Huayuan Regenerative Medicine Co Ltd
- Stanford University
- TecMed Inc
- Thermalin Inc
- TypeZero Technologies LLC
- U-Needle BV
- Universidad Autonoma de Madrid
- University of California San Francisco
- University of California Santa Barbara
- University of Cambridge
- University of Florida
- University of Minnesota
- University of Newcastle
- University of Queensland
- University of Virginia
- ViCentra BV
- WaveForm Technologies, Inc
- Xeris Biopharma Holdings Inc
- Yale University